1. Home
  2. ECOR vs NUKK Comparison

ECOR vs NUKK Comparison

Compare ECOR & NUKK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo electroCore Inc.

ECOR

electroCore Inc.

HOLD

Current Price

$7.34

Market Cap

57.1M

Sector

Health Care

ML Signal

HOLD

Logo Nukkleus Inc.

NUKK

Nukkleus Inc.

HOLD

Current Price

$2.41

Market Cap

67.9M

Sector

Finance

ML Signal

HOLD

Company Overview

Basic Information
Metric
ECOR
NUKK
Founded
2005
2013
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Electromedical & Electrotherapeutic Apparatus
Blank Checks
Sector
Health Care
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
57.1M
67.9M
IPO Year
2018
N/A

Fundamental Metrics

Financial Performance
Metric
ECOR
NUKK
Price
$7.34
$2.41
Analyst Decision
Strong Buy
Analyst Count
2
0
Target Price
$22.00
N/A
AVG Volume (30 Days)
97.1K
1.7M
Earning Date
03-11-2026
02-12-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$29,835,000.00
N/A
Revenue This Year
$28.92
N/A
Revenue Next Year
$40.87
N/A
P/E Ratio
N/A
N/A
Revenue Growth
27.90
N/A
52 Week Low
$4.16
$2.10
52 Week High
$19.49
$29.79

Technical Indicators

Market Signals
Indicator
ECOR
NUKK
Relative Strength Index (RSI) 61.22 28.70
Support Level $6.40 $2.10
Resistance Level $8.30 $3.87
Average True Range (ATR) 0.86 0.41
MACD 0.14 -0.06
Stochastic Oscillator 71.53 13.13

Price Performance

Historical Comparison
ECOR
NUKK

About ECOR electroCore Inc.

electroCore Inc is a commercial stage bioelectronic medicine company with a platform for non-invasive vagus nerve stimulation therapy initially focused on neurology. The company's product gammaCore is Food and Drug Administration cleared in the United States for adjunctive use for the preventive treatment of cluster headache in adult patients, the acute treatment of pain associated with episodic cluster headache in adult patients, the acute treatment of pain associated with migraine headache in adult patients, and the prevention of migraine in adult patients, The use of gammaCore by adolescent patients and Treatment of hemicrania continua and paroxysmal hemicrania in adult patients.

About NUKK Nukkleus Inc.

Nukkleus Inc is a financial technology company that is focused on providing software and technology solutions. The company's operating segment includes General support services and Financial services. General support services include providing software, technology, customer sales and marketing, and risk management technology hardware and software solutions package under a GSA to a related party. Financial services include providing payment services from one fiat currency to another or to digital assets. It generates maximum revenue from the General support services segment. Geographically operates in USA, UK and Malta, with majority of revenue from United Kingdom (UK).

Share on Social Networks: